Marinomed Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.5%.

Top 17 shareholders own 57% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10%	LLB Invest Kapitalanlagegesellschaft m.b.H.	169,666	€1.5m	8.59%	0.15%
7.87%	Erste Asset Management GmbH	133,350	€1.2m	0%	0.01%
7.36%	Hermann Unger	124,783	€1.1m	0%	no data
7.18%	Eva Prieschl-Grassauer	121,702	€1.1m	0%	no data
7.18%	Andreas Grassauer	121,702	€1.1m	0%	no data
4.64%	Abdulmohsen Al Sheikh	78,567	€707.1k	0%	no data
4.64%	Mohammed Al Sheikh	78,567	€707.1k	0%	no data
2.54%	Matejka & Partner Asset Management GmbH	43,009	€387.1k	0%	0.93%
2.04%	3 Banken-Generali Investment-Gesellschaft m.b.H.	34,600	€311.4k	0%	0.01%
0.87%	Sk VermÖGensverwaltung GmbH	14,765	€132.9k	0%	0.02%
0.73%	Acropora Beteiligungs GmbH	12,310	€110.8k	0%	no data
0.68%	Sparkasse Oberösterreich Kapitalanlagegesellschaft mbH	11,450	€103.0k	0%	0.04%
0.64%	amandea Vermögensverwaltung AG	10,889	€98.0k	0%	0.28%
0.38%	Vogt Asset Management Trust Reg.	6,515	€58.6k	0%	0.04%
0.13%	Gutmann Kapitalanlageaktiengesellschaft	2,150	€19.3k	0%	no data
0.097%	Fund Development & Advisory AG	1,650	€14.9k	0%	0.02%
0.016%	EB Portfoliomanagement GmbH	278	€2.5k	0%	no data